8 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

KalVista Pharmaceuticals Funding History

Since KalVista Pharmaceuticals was founded in 2004, it has participated in 5 rounds of funding. In total KalVista Pharmaceuticals has raised $234.2M. KalVista Pharmaceuticals' last funding round was on Sep 2025 for a total of $125.0M.

KalVista Pharmaceuticals Funding Rounds

Unlock 2 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Debt
Sep 2025
$125M
__
Private Placement
Nov 2024
$5M
1
DRI Healthcare Trust
Post-IPO Equity
Nov 2022
$58M
__
Series B
Jul 2015
$33M
5
Novo A/S,  SV Life Sciences,  RA Capital Management,  Longwood Fund,  Venrock
Series A
Aug 2011
$13.2M
2
Novo A/S,  SV Life Sciences

Total Funding: $234.2M

KalVista Pharmaceuticals Investors

Unlock 3 more investors →

INVESTOR

ROUND

FUNDING DATE

DRI Healthcare Trust
Private Placement
Nov 2024
Novo A/S
Series B, Series A
Jul 2015, Aug 2011
SV Life Sciences
Series B, Series A
Jul 2015, Aug 2011
RA Capital Management
Series B
Jul 2015
Longwood Fund
Series B
Jul 2015

Total Investors: 6

KalVista Pharmaceuticals has 6 investors, including DRI Healthcare Trust, Novo A/S and SV Life Sciences. The latest investment occurred in Sep 2025.